HUP9902784A3 - Indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them - Google Patents

Indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP9902784A3
HUP9902784A3 HU9902784A HUP9902784A HUP9902784A3 HU P9902784 A3 HUP9902784 A3 HU P9902784A3 HU 9902784 A HU9902784 A HU 9902784A HU P9902784 A HUP9902784 A HU P9902784A HU P9902784 A3 HUP9902784 A3 HU P9902784A3
Authority
HU
Hungary
Prior art keywords
indan
compounds
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU9902784A
Other languages
English (en)
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HU9902784D0 publication Critical patent/HU9902784D0/hu
Publication of HUP9902784A2 publication Critical patent/HUP9902784A2/hu
Publication of HUP9902784A3 publication Critical patent/HUP9902784A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HU9902784A 1998-08-21 1999-08-19 Indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them HUP9902784A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9810601A FR2782515B1 (fr) 1998-08-21 1998-08-21 NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT

Publications (3)

Publication Number Publication Date
HU9902784D0 HU9902784D0 (en) 1999-10-28
HUP9902784A2 HUP9902784A2 (hu) 2000-12-28
HUP9902784A3 true HUP9902784A3 (en) 2001-03-28

Family

ID=9529811

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902784A HUP9902784A3 (en) 1998-08-21 1999-08-19 Indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US6153625A (hu)
EP (1) EP0982305B1 (hu)
JP (1) JP2000072748A (hu)
CN (1) CN1128144C (hu)
AT (1) ATE214064T1 (hu)
AU (1) AU747494B2 (hu)
BR (1) BR9903867A (hu)
CA (1) CA2280596A1 (hu)
DE (1) DE69900961T2 (hu)
DK (1) DK0982305T3 (hu)
ES (1) ES2172294T3 (hu)
FR (1) FR2782515B1 (hu)
HK (1) HK1026212A1 (hu)
HU (1) HUP9902784A3 (hu)
NO (1) NO317516B1 (hu)
NZ (1) NZ337362A (hu)
PL (1) PL194852B1 (hu)
PT (1) PT982305E (hu)
ZA (1) ZA995321B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206514A (pt) * 2001-01-16 2004-01-06 Astrazeneca Ab Composto, método de tratamento de um ser humano ou animal que sofre de enxaqueca, uso do composto, composição farmacêutica, e, processo para preparar um composto
BR0206513A (pt) * 2001-01-16 2004-01-06 Astrazeneca Ab Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos
WO2002055012A2 (en) * 2001-01-16 2002-07-18 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103646D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chroman compounds
SE0103647D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic chromone compounds
DE10142662B4 (de) * 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
CN116283657B (zh) * 2023-02-22 2024-08-20 贵州大学 一种茚酮衍生物及其合成方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681325B1 (fr) * 1991-09-16 1993-12-17 Fabre Medicament Pierre Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AU747494B2 (en) 2002-05-16
PL335012A1 (en) 2000-02-28
PT982305E (pt) 2002-07-31
HU9902784D0 (en) 1999-10-28
JP2000072748A (ja) 2000-03-07
NO994041D0 (no) 1999-08-20
CN1250051A (zh) 2000-04-12
FR2782515B1 (fr) 2000-09-22
CN1128144C (zh) 2003-11-19
NO994041L (no) 2000-02-22
NZ337362A (en) 2000-04-28
ATE214064T1 (de) 2002-03-15
BR9903867A (pt) 2000-09-05
HK1026212A1 (en) 2000-12-08
FR2782515A1 (fr) 2000-02-25
ES2172294T3 (es) 2002-09-16
AU4463799A (en) 2000-03-09
HUP9902784A2 (hu) 2000-12-28
NO317516B1 (no) 2004-11-08
US6153625A (en) 2000-11-28
EP0982305A1 (fr) 2000-03-01
PL194852B1 (pl) 2007-07-31
DE69900961T2 (de) 2002-11-07
DK0982305T3 (da) 2002-06-24
ZA995321B (en) 2000-02-22
CA2280596A1 (fr) 2000-02-21
EP0982305B1 (fr) 2002-03-06
DE69900961D1 (de) 2002-04-11

Similar Documents

Publication Publication Date Title
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9802422A3 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and pharmaceutical compositions containing them
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP0201343A3 (en) Hypolipidemic benzothiazepine compounds, process for their preparation and pharmaceutical compositions containing them
HUP0103333A3 (en) Pyrroloindoles, pyridoindoles and azepinoindiles as 5-ht2c agonists, process for their preparation and pharmaceutical compositions containing them
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0102512A3 (en) Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
HUP0102334A3 (en) Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing the compound
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0000901A3 (en) 16-hydroxy-11(substituted phenyl)-estra-4,9-diene derivatives, process for their preparation and pharmaceutical compositions containing them
IL137494A0 (en) Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶,其製備方法以及含該化合物的藥物組合物
HUP0102622A3 (en) Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them
HUP0003577A3 (en) Tetrahydro gamma-carbolines, process for their preparation, their use and pharmaceutical compositions containing them
HUP0100489A3 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP9800865A3 (en) Condensed piperidine-derivatives, process for producing them and pharmaceutical compositions containing them
EG23760A (en) Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them
HUP0101098A3 (en) Streptogramin derivatives, process for preparation thereof and compositions containing same
HUP9902784A3 (en) Indan-1-ol compounds, process for their preparation and pharmaceutical compositions containing them
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them